Publication Name	World Journal of Psychiatry
Manuscript ID	92728
Country	United States

Received	2024-02-04 03:27
Peer-Review Started	2024-02-04 03:27
To Make the First Decision
Return for Revision	2024-04-13 19:28
Revised	2024-04-20 21:55
Second Decision	2024-04-26 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-26 06:08
Articles in Press	2024-04-26 06:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-09 12:30
Publish the Manuscript Online	2024-05-16 07:58

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Review
Article Title	Neurosurgical and pharmacological management of dystonia
Manuscript Source	Invited Manuscript
All Author List	Ali Ahmed Mohamed, Steven Faragalla, Asad Khan, Garrett Flynn, Gersham Rainone, Phillip Mitchell Johansen and Brandon Lucke-Wold
Funding Agency and Grant Number
Corresponding Author	Brandon Lucke-Wold, MD, PhD, Neurosurgeon, Department of Neurosurgery, University of Florida, 1505 SW Archer Road, Gainesville, FL 32611, United States. brandon.lucke-wold@neurosurgery.ufl.edu
Key Words	Botulinum toxin; Magnetic resonance imaging-guided focused ultrasound; Surgical ablation; Deep brain stimulation; Peripheral denervation surgery; Antipsychotics
Core Tip	Dystonia is a neurological movement disorder affecting different regions of the body with variable responses to current interventions. Pharmacological agents, such as oral anticholinergic and botulinum toxin injection, play a major role in the initial treatment of patients. However severe and/or refractory cases require the identification and targeting of focal areas for neurosurgical intervention. Deep brain stimulation (DBS) targets these anatomical locations to manage symptoms. Surgical ablation procedures and peripheral denervation surgeries also offer potential treatment to patients who do not respond to DBS.
Publish Date	2024-05-16 07:58
Citation	<p>Mohamed AA, Faragalla S, Khan A, Flynn G, Rainone G, Johansen PM, Lucke-Wold B. Neurosurgical and pharmacological management of dystonia. <i>World J Psychiatry</i> 2024; 14(5): 624-634</p>
URL	https://www.wjgnet.com/2220-3206/full/v14/i5/624.htm
DOI	https://dx.doi.org/10.5498/wjp.v14.i5.624

Full Article (PDF)	WJP-14-624-with-cover.pdf
Manuscript File	92728_Auto_Edited-YJP.docx
Answering Reviewers	92728-Answering reviewers.pdf
Audio Core Tip	92728-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	92728-Conflict-of-interest_statement.pdf
Copyright License Agreement	92728-Copyright license agreement.pdf
Supplementary Material	92728-Supplementary material.pdf
Peer-review Report	92728-Peer-review(s).pdf
Scientific Misconduct Check	92728-Bing-Chen YL-2.png
Scientific Editor Work List	92728-Scientific editor work list.pdf
CrossCheck Report	92728-CrossCheck report.pdf